<DOC>
	<DOCNO>NCT00087776</DOCNO>
	<brief_summary>The primary objective trial compare survival patient metastatic malignant melanoma treat Taxoprexin Injection treat Dacarbazine . In addition , response rate drug , response duration , time progression time treatment failure measure . Toxicity evaluate compare two group .</brief_summary>
	<brief_title>Study Taxoprexin Injection vs. Dacarbazine Patients With Metastatic Malignant Melanoma</brief_title>
	<detailed_description />
	<mesh_term>Melanoma</mesh_term>
	<criteria>Patients must malignant melanoma , document metastatic disease . Patients must least one unidimensionally measurable lesion . Patients must receive prior systemic chemotherapy metastatic disease . Prior treatment immunotherapy vaccine therapy allow provide documentation disease progression . At least 6 week ( 42 day ) since prior immunotherapy , cytokine , biologic , vaccine therapy unless patient progressed immunotherapy . At least 4 week ( 28 day ) since prior radiotherapy . Lesions use assess disease status may radiate . Patients must ECOG performance status 0 2 . Patients must &gt; = 18 year age . Patients must adequate renal liver function Patients must adequate bone marrow function . Life expectancy least 3 month . Patients must sign informed consent form indicate aware investigational nature study keep policy institution . Patients receive prior therapy taxane dacarbazine . Patients whose primary site eye . Patients past current history neoplasm entry diagnosis , except curatively treat nonmelanoma skin cancer carcinoma situ cervix cancer cure surgery alone diseasefree survival longer 5 year . Patients uncontrolled brain metastasis . Patients pregnant nursing patient practice acceptable method birth control . Patients may breastfeed study . Patients current active infection require antiinfectious treatment ( e.g. , antibiotic , antiviral , antifungal ) . Patients current peripheral neuropathy etiology great grade 1 . Patients unstable serious concurrent medical condition exclude . Patients know hypersensitivity Cremophor . Patients must recent major surgery within past 14 day large field radiation therapy , chemotherapy , endocrine therapy last 28 day , biologic therapy last 42 day .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2011</verification_date>
</DOC>